SARA MAYA: Open Payments
NPI 1669613378 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$242 in 14 payments from 7 companies in 2025. Trend: 2023 $181 · 2024 $224 · 2025 $242
Food & beverage: $242
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Amgen Inc. | 3 | $49 |
| Aimmune Therapeutics, Inc. | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Novo Nordisk Inc | 2 | $32 |
| Lilly USA, LLC | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
Products named: AIRSUPRA, VOWST, Kerendia, Rybelsus, EVENITY, OTEZLA, MOUNJARO.
Industry payments across CA — which companies pay providers there.
